Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
flu; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced influenza (Verbatim: flu). The outcome of the influenza was not reported. It was unknown if the reporter considered the influenza to be related to RSV vaccine. It was unknown if the company considered the influenza to be related to RSV vaccine. Additional Information: GSK receipt date: 15-MAY-2025 This case was reported by a patient via interactive digital media. The patient had been coughing for months and initially blamed it on pollen. Then the cough worsened, and his/her eyes and nose started running. He/she developed a sore throat, along with body aches and pain. He/she was planning to see the doctor in the morning (On the day of reporting). He/she had already received an RSV shot but was worried that it might have been the flu.